What is Maccura Biotechnology Co Operating Cash Flow per Share?
Maccura Biotechnology Co's operating cash flow per share for the
three
months ended in Mar. 2025 was ¥0.09.
Maccura Biotechnology Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1.12.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Maccura Biotechnology Co was -7.50% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -29.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -1.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 38.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Maccura Biotechnology Co's Operating Cash Flow per Share or its related term are showing as below:
SZSE:300463'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -38.2 Med: 10.4 Max: 140
Current: -29.1
During the past 13 years, Maccura Biotechnology Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 140.00% per year. The lowest was -38.20% per year. And the median was 10.40% per year.
SZSE:300463's 3-Year OCF Growth Rate is ranked worse than 87.79% of 172
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.35
vs SZSE:300463: -29.10
Maccura Biotechnology Co Operating Cash Flow per Share Historical Data
The historical data trend for Maccura Biotechnology Co's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Maccura Biotechnology Co Operating Cash Flow per Share Chart
Competitive Comparison of Maccura Biotechnology Co's Operating Cash Flow per Share
For the Diagnostics & Research subindustry, Maccura Biotechnology Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maccura Biotechnology Co's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Maccura Biotechnology Co's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.12
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maccura Biotechnology Co Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Maccura Biotechnology Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300463 has been successfully added to your 